Literature DB >> 22465633

Development of a nanoparticle-based system for the delivery of retinoic acid into macrophages.

Eyad Almouazen1, Sandrine Bourgeois, Ali Boussaïd, Pascale Valot, Celine Malleval, Hatem Fessi, Serge Nataf, Stephanie Briançon.   

Abstract

The aim of the present work is to prepare nanoparticulate systems that can target and modulate the functions of mononuclear phagocytes by local administration. All-trans retinoic acid (RA) was chosen as an immunomodulator to be encapsulated in biodegradable nanoparticles (NP). Different formulations were prepared by the nanoprecipitation method and poly(d,l)lactic acid based nanocapsules (NC) were selected to continue the study. RA-NC demonstrated a sustained release profile and an enhanced stability for 7 days. The uptake of fluorescent (NileRed) labeled NP was conducted on bone marrow derived macrophages (BMM) in vitro and xenograft glioma nude mice in vivo. Fluorescent microscopy observations and flow cytometry analysis demonstrated that NR-NC were engulfed by BMM in vitro and lasted inside over 7 days. The intratumoral injection of NR-NC confirmed that NC were efficiently uptaken by infiltrated macrophages. The effects of RA loaded NC on BMM were also evaluated by RT(2)-PCR array. Our results suggest that polymeric nanoparticles are suitable carriers to deliver RA into macrophages and can offer a new strategy in tumor macrophage-based treatment.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22465633     DOI: 10.1016/j.ijpharm.2012.03.025

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

1.  Rapid Serum-Free Isolation of Oligodendrocyte Progenitor Cells from Adult Rat Spinal Cord.

Authors:  John Bianco; Dario Carradori; Ronald Deumens; Anne des Rieux
Journal:  Stem Cell Rev Rep       Date:  2017-08       Impact factor: 5.739

2.  A novel controlled release formulation of the Pin1 inhibitor ATRA to improve liver cancer therapy by simultaneously blocking multiple cancer pathways.

Authors:  Dayun Yang; Wensong Luo; Jichuang Wang; Min Zheng; Xin-Hua Liao; Nan Zhang; Wenxian Lu; Long Wang; Ai-Zheng Chen; Wen-Guo Wu; Hekun Liu; Shi-Bin Wang; Xiao Zhen Zhou; Kun Ping Lu
Journal:  J Control Release       Date:  2017-11-21       Impact factor: 9.776

3.  Nano-encapsulation of vitamin D3 active metabolites for application in chemotherapy: formulation study and in vitro evaluation.

Authors:  Eyad Almouazen; Sandrine Bourgeois; Lars Petter Jordheim; Hatem Fessi; Stephanie Briançon
Journal:  Pharm Res       Date:  2012-12-08       Impact factor: 4.200

4.  Protein-Based Nanoparticle Preparation via Nanoprecipitation Method.

Authors:  Mohamad Tarhini; Ihsane Benlyamani; Selim Hamdani; Géraldine Agusti; Hatem Fessi; Hélène Greige-Gerges; Abderrazzak Bentaher; Abdelhamid Elaissari
Journal:  Materials (Basel)       Date:  2018-03-07       Impact factor: 3.623

5.  Polycaprolactone/maltodextrin nanocarrier for intracellular drug delivery: formulation, uptake mechanism, internalization kinetics, and subcellular localization.

Authors:  Maxwell Korang-Yeboah; Yamini Gorantla; Simon A Paulos; Pankaj Sharma; Jaideep Chaudhary; Ravi Palaniappan
Journal:  Int J Nanomedicine       Date:  2015-07-29

Review 6.  Particles from preformed polymers as carriers for drug delivery.

Authors:  K Miladi; D Ibraheem; M Iqbal; S Sfar; H Fessi; A Elaissari
Journal:  EXCLI J       Date:  2014-02-03       Impact factor: 4.068

7.  The Fabrication and in vitro Evaluation of Retinoic Acid-Loaded Electrospun Composite Biomaterials for Tracheal Tissue Regeneration.

Authors:  Cian O'Leary; Luis Soriano; Aidan Fagan-Murphy; Ivana Ivankovic; Brenton Cavanagh; Fergal J O'Brien; Sally-Ann Cryan
Journal:  Front Bioeng Biotechnol       Date:  2020-03-20

Review 8.  Advances and challenges in retinoid delivery systems in regenerative and therapeutic medicine.

Authors:  Raquel Ferreira; Joseph Napoli; Tariq Enver; Liliana Bernardino; Lino Ferreira
Journal:  Nat Commun       Date:  2020-08-26       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.